Table 3.

Drug Treatment at Baseline and at the End of the Study (i.e. After 6 Months)

	Baseline n=697	End of Study n=697	p
Diuretics	34.5	48.7	<0.0001
ACEIs	30.3	49.6	<0.0001
ARBs	29.6	45.2	<0.0001
Beta-blockers	24.3	31.7	NS
Calcium antagonists	29.8	43.5	<0.0001
Fixed combinations	20.3	37.2	<0.0001
Antidiabetic drugs	13.6	14.2	NS
Statins	24.8	39.2	<0.0001
Fibrates	1.3	1.8	NS
Aspirin	12.6	18.5	<0.0001

All numbers express percent of patients.

ACEIs, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers; NS, not significant.